一种基于机器学习的方法,用于预测Hypericum perforatum L.的抗凝活性,并评估化合物活性
Zhiyong Zhang1, Wennan Nie1, Yijing Zhang1
1College of Pharmaceutical Engineering of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Phytochemical analysis : PCA
|November 17, 2024
概括
这项研究揭示了Hypericum perforatum L. (HPL) 的分支具有显著的抗凝活性. 机器学习模型准确地预测了化合物活性,加速了从这种药用植物中选新型治疗剂.
科学领域:
- 植物化学 植物化学
- 药理学 药理学是指药理学的学科.
- 计算化学计算化学
背景情况:
- (Hypericum perforatum L.) (HPL) 是一种被广泛研究的药用植物,其抗凝性质尚不清楚.
- 之前的研究没有报告HPL的抗凝活性或特定生物活性成分.
研究的目的:
- 开发一种机器学习 (ML) 模型,用于预测HPL的抗凝活性.
- 评估HPL中的化合物的活性,并确定关键贡献者.
主要方法:
- 对HPL提取物进行了体外抗凝剂活性测定.
- 超高性能液体染色学-四极点飞行时间质谱法 (UPLC-Q-TOF-MS) 用于化合物分析.
- 九种独立的ML方法和两种组合方法用于活动预测和特征重要性分析.
主要成果:
- 24种化合物表现出显著的抗凝剂活性.
- 分子对接证实了这些化合物的活性.
- 确定HPL分支具有强大的,以前未知的抗凝剂作用.
结论:
- 开发的ML模型准确可靠地预测HPL抗凝剂活性,提高查效率.
- 这项研究强调了HPL分支作为抗凝化合物的来源的潜力.
- 建议对HPL的抗凝性质进行进一步的研究.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K


